Back to top

Image: Bigstock

Azul Reports Increase in Traffic and Load Factor in May

Read MoreHide Full Article

With air-travel demand increasing gradually, Azul S.A. (AZUL - Free Report) reported impressive May traffic numbers. Both domestic as well as international demand and supply increased on a month-over-month basis. Moreover, consolidated load factor (% of seats filled by passengers) inched up since consolidated traffic demand was more than the capacity expansion.

Consolidated traffic (measured in revenue passenger kilometers or RPKs) surged 51.6% on a month-on-month basis. Apart from a significant increase of 64.8% in international traffic, the metric increased 49.1% on the domestic front, thereby buoying the overall figure. Consolidated capacity (measured in available seat kilometers/ASKs) increased 44.8% due to 40.5% and 65.3% rise in domestic and international capacity, respectively from the past month.

Consolidated load factor rose to 72% (or 3.2 percentage points). Domestic load factor rose 4.3 percentage points to 74.1 while international load factor declined 0.2 percentage points to 63.8% from April level.

Zacks Ranks & Key Picks

Azul currently carries a Zacks Rank #3 (Hold).

A few better-ranked stocks in the Zacks Transportation sector are Air Lease Corporation (AL - Free Report) , Ryanair Holdings plc (RYAAY - Free Report) and Teekay Tankers Ltd. (TNK - Free Report) . All the stocks carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Long-term earnings (three to five years) growth rate for Air Lease, Ryanair Holdings and Teekay Tankers is estimated at 3.1%, 20.5% and 3%, respectively.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>
 

Published in